The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation

Eva Segelov; Kate Wilson; Val Gebski; Paul Waring; Jayesh Desai; Louise Nott; Christos Karapetis; M Hall; Harpreet Wasan; Jeremy Shapiro

The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation

Eva Segelov, Kate Wilson, Val Gebski, Paul Waring, Jayesh Desai, Louise Nott, Christos Karapetis, M Hall, Harpreet Wasan, Jeremy Shapiro

Research output: Contribution to conference › Poster

Original language	English
Pages	155
Number of pages	1
Publication status	Published - 2013
Externally published	Yes

Cite this

@conference{e174f78dfcee4884bc4e229864bcf0ee,

title = "The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation",

author = "Eva Segelov and Kate Wilson and Val Gebski and Paul Waring and Jayesh Desai and Louise Nott and Christos Karapetis and M Hall and Harpreet Wasan and Jeremy Shapiro",

year = "2013",

language = "English",

pages = "155",

}

TY - CONF

T1 - The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation

AU - Segelov, Eva

AU - Wilson, Kate

AU - Gebski, Val

AU - Waring, Paul

AU - Desai, Jayesh

AU - Nott, Louise

AU - Karapetis, Christos

AU - Hall, M

AU - Wasan, Harpreet

AU - Shapiro, Jeremy

PY - 2013

Y1 - 2013

M3 - Poster

SP - 155

ER -